Latest Commercialisation News

Weebit Nano has successfully raised A$87 million through institutional and Israeli placements, positioning itself to fast-track its advanced ReRAM technology development. The capital raise includes a forthcoming share purchase plan for retail investors.

Temas Resources has formed a Scientific Advisory Board of hydrometallurgical leaders to accelerate the rollout of its innovative Regenerative Chloride Leaching technology, promising major cost and environmental benefits in critical minerals processing.

Firebrick Pharma has secured its first regulatory approval for Nasodine Nasal Spray in Indonesia, paving the way for entry into Southeast Asia’s largest market. This milestone marks a significant step in the company’s international expansion strategy.

InFocus Group Holdings has completed Codexa, a proprietary sweepstakes casino platform targeting the booming US market, with plans for licensing and potential sale.

Finder Energy has achieved a pivotal regulatory milestone with approval of the Development Area for its Kuda Tasi and Jahal oil fields, setting the stage for project sanction and a scalable production hub in Timor-Leste.

Weebit Nano has launched a significant A$80 million institutional placement, alongside additional funding initiatives, to accelerate its ReRAM technology leadership and broaden AI-related offerings.

Diatreme Resources has reported promising aircore drilling outcomes from its Si2 and Casuarina silica sand deposits in Far North Queensland, underpinning resource upgrades and expansion potential. These results bolster the company’s position in the growing specialty glass and solar PV markets.

GCM Corporation has completed the full transfer of its proprietary Very High Density (VHD) technology, gaining exclusive global ownership with payments tied to future revenue milestones.

EBR Systems has implemented a one-for-ten reverse stock split of its common shares, adjusting the CHESS Depositary Interest (CDI) conversion ratio to maintain investor value. This move restructures the company’s equity without altering the overall value per CDI.

Nexsen Limited is advancing its rapid Group B Streptococcus test, StrepSure®, with a clear FDA submission timeline and early market entries across Asia-Pacific and emerging regions.

Condor Energy has identified extensive deepwater turbidite reservoirs across its TEA-86 offshore acreage in Peru’s Tumbes Basin, significantly reducing exploration risk and advancing plans for drilling and licence conversion.

Eve Health Group is advancing its proprietary reformulation platform with two fast-onset products launched under Australia's SAS-B pathway, targeting large underserved markets in women's and men's health. The company’s capital-light, partner-led model aims for rapid revenue growth post-ARTG registration.